Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Operating Expenses (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Operating Expenses came in at $59.8 million in Q1 2026, up 1.19% YoY from $59.1 million in Q1 2025, and up 4.05% on a QoQ basis from $57.5 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Operating Expenses (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Operating Expenses data on file, last reported at $59.8 million in Q1 2026.

  • Quarterly Operating Expenses rose 1.19% year-over-year to $59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235.1 million (up 17.62% YoY) and the FY2025 annual result came in at $234.4 million, up 25.44% from the prior year.
  • Operating Expenses improved to $59.8 million in Q1 2026, from $57.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $95.8 million in Q1 2022 to a low of $46.1 million in Q1 2024.
  • A 5-year average of $64.7 million and a median of $59.8 million in 2026 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2022 — Operating Expenses jumped 89.42% — and 2024, when it slumped 43.44%.
  • Tracing KOD's Operating Expenses over 5 years: stood at $74.1 million in 2022, then declined by 14.44% to $63.4 million in 2023, then slipped by 27.13% to $46.2 million in 2024, then advanced by 24.41% to $57.5 million in 2025, then advanced by 4.05% to $59.8 million in 2026.
  • The last three Operating Expenses figures came in at $59.8 million (Q1 2026), $57.5 million (Q4 2025), and $62.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 66.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.84 Mn
Mar 31, 2026 59.78 Mn
Dec 31, 2025 57.45 Mn
Sep 30, 2025 62.35 Mn
Jun 30, 2025 55.51 Mn
Mar 31, 2025 59.07 Mn
Dec 31, 2024 46.18 Mn
Sep 30, 2024 46.63 Mn
Jun 30, 2024 47.98 Mn
Mar 31, 2024 46.06 Mn
Dec 31, 2023 63.37 Mn
Sep 30, 2023 54.50 Mn
Jun 30, 2023 84.83 Mn
Mar 31, 2023 74.62 Mn
Dec 31, 2022 74.07 Mn
Sep 30, 2022 79.48 Mn
Jun 30, 2022 92.07 Mn
Mar 31, 2022 95.77 Mn
Dec 31, 2021 93.05 Mn
Sep 30, 2021 67.54 Mn